Literature DB >> 8296

Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat.

R M Welch, C R Hughes, R L Deangelis.   

Abstract

A thin-layer chromatographic procedure is described for the quantitative determination of phenacetin and acetaminophen in rat plasma. The method was used to determine the effect of 3-methylcholanthrene (3-MC) on the disposition and bioavailability of phenacetin following its oral and iv administration to rats. Pretreatment with 3-MC decreased the plasma half-life of phenacetin, after iv administration, from 28 min to 4.5 min and reduced the systemic bioavailability of phenacetin, after oral administration, from 45% in control rats to 6% in 3-MC-treated rats. By comparing the plasma levels of phenacetin in the portal circulation with those in the peripheral circulation, following the oral administration of phenacetin, it was concluded that the 7-fold reduction in the bioavailability of phenacetin observed in 3-MC treated rats was caused by a marked increase in the metabolism of phenacetin during its first pass through the liver.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 8296

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

Review 1.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

2.  Theoretical considerations on two equations for estimating the extent of absorption after oral administration of drugs.

Authors:  Y Kwon; P B Inskeep
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

Review 3.  Role of tobacco smoking in pharmacokinetics.

Authors:  W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

4.  A pharmacokinetic model to differentiate preabsorptive, gut epithelial, and hepatic first-pass metabolism.

Authors:  W A Colburn
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

Review 5.  Influence of age and smoking on drug kinetics in man: studies using model compounds.

Authors:  R E Vestal; A J Wood
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

6.  Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs.

Authors:  Yawen Yuan; Qingfeng He; Shunguo Zhang; Min Li; Zhijia Tang; Xiao Zhu; Zheng Jiao; Weimin Cai; Xiaoqiang Xiang
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

7.  Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo.

Authors:  Sang-Bum Kim; Kyu-Sang Kim; Heon-Min Ryu; Seong-Ho Hong; Bo-Kyoung Kim; Dae-Duk Kim; Jin Woo Park; In-Soo Yoon
Journal:  Molecules       Date:  2018-06-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.